References
- Bacci G, Picci P, Ferrari S, Ruggieri P, Casadei R, Tienghi A, Brach del Prever A, Gherlinzoni F, Mercuri M, Monti C. Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremity. Results in 164 patients preoperatively treated with high-dose methotrexate (iv) followed by cisplatin and doxorubicin. Cancer 1993; 72: 3227–38
- Bramwell V H C, Burgers M, Sneath R, Souhami R, Van Oosterom A T, Voute P A, Rouesse J, Spooner D, Craft A W, Somers R, Pringle J, Malcom A J, Van der Eijken J, Thomas D, Uscinska B, Machin D, van Glabbeke M. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study by the European Osteosarcoma Intergroup. J Clin Oncol 1992; 10: 1579–91
- Campanacci M, Laus M. Local recurrence after amputation for osteosarcoma. J Bone and Joint Surg (Br) 1980; 62: 201–7
- Campanacci M, Bacci G, Bertoni F, Picci P, Minutillo A, Franceschi C. The treatment of osteosarcoma of the extremity : twenty years' experience at the Istituto Ortopedi-co Rizzoli. Cancer 1981; 48: 1456–61
- Delepine N, Delepine G, Alkallaf S, Voisin M C, Desbois J C, Debre R. Local relapses following limb-sparing salvage surgery for osteosarcoma. Prognostic factors and influence of chemotherapy. ASCO Proceedings 1996; 15: 526
- Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. J Clin Oncol 1987; 5: 21–6
- Enneking W F, Kagan A. The implications of skip metastases in osteosarcoma. Clin Orthop 1975; 111: 33–41
- Enneking W F, Spanier S S, Goodman M A. Current concepts review. The surgical staging of musculoskeletal sarcoma. J Bone Joint Surg (Am) 1980; 62: 1027–30
- Kempf-Bielack B, Bielack S, Bieling P, Delling G, Fuchs N, Heise U, Kotz R, Werner M, Windhager R, Winkelmann W, Winkler K. Local failure (LF) of osteosarcoma (OS): Risk factors and prognosis. Results of the cooperative OS study group C. O. S. S. ASCO Proceedings 1996; 15: 520
- Link M P, Goorin A M, Miser A W, Green A A, Pratt C B, Belasco J B, Pritchard J, Malpas J S, Baker A R, Kirk-Patrick J A, Ayala A G, Shuster J J, Abelson H T, Simone J V, Vietti T J. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986; 314: 1600–6
- Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U, Galletti S, Gherlinzoni F, Calderoni P, Sudanese A, Baldi-Ni N, Bernini M, Jaffe N. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy. Regional mapping of viable and nonviable tumor. Cancer 1985; 56: 1515–21
- Picci P, Sangiorgi L, Rougraff B T, Neff J R, Casadei R, Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 1994; 12: 2699–705
- Picci P, Sangiorgi L, Bahamonde L, Aluigi P, Bibiloni J, Zavatta M, Mercuri M, Briccoli A, Campanacci M. Risk factors for local recurrences after limb-salvage surgery for high grade osteosarcoma of the extremities. Ann Oncol 1997; 8: 899–903
- Price C H G, Zhuber K, Salzer-Kuntschik M, Salzer M, Wil-Lert H G, Immenkamp M, Groh P, Matejovsky Z, Keyl V. Osteosarcoma in children. J Bone Joint Surg (Br) 1975; 57: 341–5
- Rosen G, Caparros B, Huvos A G, Kosloff C, Nirenberg A, Cacavio A, Marcove R C, Lane J M, Mehta B, Urban C. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221–30
- Rougraff B T, Simon M A, Kneisl J S, Greenberg D B, Man-Kin H J. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg (Am) 1994; 76: 649–55
- Saeter G, Alvegard T A, Elomaa I, Stenwig A E, Holmstrom T, Solheim O P. Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high dose methotrexate: A Scandinavian Sarcoma Group Study. J Clin Oncol 1991; 9: 1766–75
- Winkler K, Bieling P, Bielack S, Delling G, Dose C, Jurgens H, Kotz R, Ritter J, Salzer-Kuntschik M. Local control and survival from the Cooperative Osteosarcoma Study Group Studies of German Society of Pediatric Oncology and the Vienna Bone Tumor Registry. Clin Orthop 1991; 270: 79–86